再生障碍性贫血中西医发病机制与其治疗进展-石岭,王运律.pdfVIP

第16卷  第5期 辽宁中医药大学学报 Vol. 16 No. 5      2014 年 5 月 JOURNAL OF LIAONING UNIVERSITY OF TCM May，2014 DOI：10.13194/j.issn.1673-842x.2014.05.025 再生障碍性贫血中西医发病机制及其治疗进展 石岭，指导：王运律 （上海中医药大学附属市中医医院，上海 200071 ） 再生障碍性贫血是造血系统难治性疾病之一，其发病机制至今尚未完全阐明，而对其有效治疗又有赖 摘 要： 于对其发病机制的进一步研究。对于再生障碍性贫血的治疗，传统医学和现代医学各有其独特的优势，同时也各有 其不足，而中西医结合治疗本病却可以取长补短，标本兼治。文章主要从再生障碍性贫血的中西医发病机制及治疗 方面做一简要综述，以期为中西医结合治疗本病的研究提供依据。 关键词：再生障碍性贫血；发病机制；治疗；中西医结合 ( ) 中图分类号：R556.5 文献标志码：A 文章编号：1673-842X 2014 05- 0074- 03 Progress of Pathogenesis and Treatment of Aplastic Anemia in Traditional Chinese Medicine and Western Medicine SHI Ling，Advisor：WANG Yunlyu （Shanghai Hospital of Troditional Chinese Medicine Affiliated to Shanghai University of Traditional Chinese Medicine，Shanghai 200071，China） Abstract：Aplastic anemia is one of the refractory diseases of the hematopoietic system，which pathogenesis has not been fully elucidated yet. However，the effective treatments of aplastic anemia still depend on the further study of its pathogenesis. For treatment of aplastic anemia，traditional Chinese medicine and Western medicine both have their own advantages and disadvantages. But combining treatment of traditional Chinese medicine with Western medicine can draw on each others strength and treat symptoms and root causes. In order to provide bases for the research of combining traditional Chinese medicine with Western medicine to treat aplastic anemia，this artical tries to review the pathogenesis and treatment of aplasti